Auxesis Pharma Holding AB has signed a license agreement with Pharma America Corp. in Florida, for a powerful introduction to the entire Americas.

The ASA.P® product line, that is the first range of products for market introduction, targets the entire global topical pain relief market and other segments.

Auxesis Pharma plans to work worldwide with licensing of the company’s approvals to pharmaceutical companies.